Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 02, 2015 7:43 AM ET

Biotechnology

Company Overview of Genomics USA, Inc.

Company Overview

Genomics USA, Inc. develops and fabricates micro array technologies to bypass DNA purification and quantitation by allowing human leukocyte antigen (HLA) typing directly from raw blood (rehydrated) dried blood spots on Guthrie cards and from raw buccalswabs. It offers HLA Chip technology based on HLA typing for tissue transplantation and stem cell therapeutics, as well as based on HLA analysis for vaccine development, personalized vaccine delivery, personalized treatment for autoimmune diseases, and personalized treatment of microbial infection. Genomics USA was incorporated in 2004 and is based in Inverness, Illinois.

1622 West Colonial Parkway

Suite 1A

Inverness, IL 60067

United States

Founded in 2004

Phone:

847-359-1032

Fax:

847-359-1053

Key Executives for Genomics USA, Inc.

Co-Founder, Chief Executive Officer and President
Co-Founder, Chief Scientific Officer and Chairman of Scientific Advisory Board
Age: 63
Chief Financial Officer
ASHI Director and HLA Advisor
Vice President of Intellectual Property
Compensation as of Fiscal Year 2015.

Genomics USA, Inc. Key Developments

RWE AG and E.ON SE Select GENUSA to Provide Fuel Reloads at Gundremmingen Unit C

RWE AG and E.ON SE have selected GNF ENUSA Nuclear Fuel S.A., or GENUSA, to provide fuel reloads for unit C of the Gundremmingen nuclear power station in Gundremmingen, Germany. The three reloads and options for two more included in the agreement will potentially provide fuel to the plant during its remaining lifetime. GENUSA previously provided fuel to Gundremmingen Unit C, having delivered about 1,100 fuel bundles. The GNF2 performance fuel assembly is designed to deliver increased energy output while decreasing overall fuel cycle costs. GNF2's advanced design saves utilities money by reducing the total amount of uranium and the average enrichment in fuel reloads.

Similar Private Companies By Industry

Company Name Region
Native Traits Corp United States
OxyBand Technologies, Inc. United States
ProhibiTx, Inc. United States
Tissuetech, Inc. United States
Parcell Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genomics USA, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.